BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29718791)

  • 1. Radioembolization in Advanced Hepatocellular Carcinoma.
    Riaz A; Lewandowski R; Salem R
    J Clin Oncol; 2018 Jul; 36(19):1898-1901. PubMed ID: 29718791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can Stereotactic Body Radiotherapy Effectively Treat Hepatocellular Carcinoma?
    Barry A; Knox JJ; Wei AC; Dawson LA
    J Clin Oncol; 2016 Feb; 34(5):404-8. PubMed ID: 26700118
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Abouchaleh N; Gabr A; Ali R; Al Asadi A; Mora RA; Kallini JR; Mouli S; Riaz A; Lewandowski RJ; Salem R
    J Nucl Med; 2018 Jul; 59(7):1042-1048. PubMed ID: 29217739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent Chemotherapy and Radiation Therapy for Inoperable Locally Advanced Non-Small-Cell Lung Cancer.
    Rosenzweig KE; Gomez JE
    J Clin Oncol; 2017 Jan; 35(1):6-10. PubMed ID: 27870565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of High-Dose Chemotherapy With Autologous Stem-Cell Rescue in Men With Previously Treated Germ Cell Tumors.
    Pagliaro LC
    J Clin Oncol; 2017 Apr; 35(10):1036-1040. PubMed ID: 27992270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which Patients With Cervical Squamous Cell Carcinoma Might Benefit From Neoadjuvant Chemotherapy?
    Mahmoud O; Einstein MH
    J Clin Oncol; 2018 Jun; 36(16):1543-1547. PubMed ID: 29668367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decision Making in a Data-Poor Environment: Management of Brain Metastases From Testicular and Extragonadal Germ Cell Tumors.
    Gilligan T
    J Clin Oncol; 2016 Feb; 34(4):303-6. PubMed ID: 26668343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Open-label prospective study of the safety and efficacy of glass-based yttrium 90 radioembolization for infiltrative hepatocellular carcinoma with portal vein thrombosis.
    Kokabi N; Camacho JC; Xing M; El-Rayes BF; Spivey JR; Knechtle SJ; Kim HS
    Cancer; 2015 Jul; 121(13):2164-74. PubMed ID: 25847227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing Treatment Risk and Benefit for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Right Treatment for the Right Patient.
    Presley CJ; Gross CP; Lilenbaum RC
    J Clin Oncol; 2016 May; 34(13):1438-42. PubMed ID: 27001591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Stage II Germ Cell Tumors: Be Sure, Be Patient, Be Safe.
    Kollmannsberger CK; Nappi L; Nichols C
    J Clin Oncol; 2019 Aug; 37(22):1856-1862. PubMed ID: 31180818
    [No Abstract]   [Full Text] [Related]  

  • 11. Favorable survival time provided with radioembolization in hepatocellular carcinoma patients with and without portal vein thrombosis.
    Ozkan ZG; Poyanli A; Ucar A; Kuyumcu S; Akyuz F; Keskin S; Saglam S; Yilmaz E; Karaca C; Turkmen C
    Cancer Biother Radiopharm; 2015 Apr; 30(3):132-8. PubMed ID: 25760644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.
    Vilgrain V; Pereira H; Assenat E; Guiu B; Ilonca AD; Pageaux GP; Sibert A; Bouattour M; Lebtahi R; Allaham W; Barraud H; Laurent V; Mathias E; Bronowicki JP; Tasu JP; Perdrisot R; Silvain C; Gerolami R; Mundler O; Seitz JF; Vidal V; Aubé C; Oberti F; Couturier O; Brenot-Rossi I; Raoul JL; Sarran A; Costentin C; Itti E; Luciani A; Adam R; Lewin M; Samuel D; Ronot M; Dinut A; Castera L; Chatellier G;
    Lancet Oncol; 2017 Dec; 18(12):1624-1636. PubMed ID: 29107679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration of Anti-Programmed Death-1 Therapy in Advanced Melanoma: How Much of a Good Thing Is Enough?
    Khushalani NI
    J Clin Oncol; 2018 Jun; 36(17):1649-1653. PubMed ID: 29389234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative Management of Resected Brain Metastases: When Can Radiotherapy Be Deferred?
    Mehta MP; Kotecha R
    J Clin Oncol; 2018 Oct; ():JCO2018793232. PubMed ID: 30296192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation.
    Sangro B; Carpanese L; Cianni R; Golfieri R; Gasparini D; Ezziddin S; Paprottka PM; Fiore F; Van Buskirk M; Bilbao JI; Ettorre GM; Salvatori R; Giampalma E; Geatti O; Wilhelm K; Hoffmann RT; Izzo F; Iñarrairaegui M; Maini CL; Urigo C; Cappelli A; Vit A; Ahmadzadehfar H; Jakobs TF; Lastoria S;
    Hepatology; 2011 Sep; 54(3):868-78. PubMed ID: 21618574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of Risk Stratification in Localized Prostate Cancer.
    Morgans AK
    J Clin Oncol; 2018 Feb; 36(6):528-532. PubMed ID: 29303624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporating Androgen Deprivation With Dose-Escalated External-Beam Radiotherapy for Prostate Cancer.
    Dosoretz AP; Yu JB
    J Clin Oncol; 2016 May; 34(15):1718-22. PubMed ID: 27001587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Brain Metastases in ALK-Positive Non-Small-Cell Lung Cancer.
    Rusthoven CG; Doebele RC
    J Clin Oncol; 2016 Aug; 34(24):2814-9. PubMed ID: 27298405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate Cancer Radiotherapy: An Evolving Paradigm.
    Catton CN; Lukka H; Martin J
    J Clin Oncol; 2018 Oct; 36(29):2909-2913. PubMed ID: 30138084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival after 131I-labeled lipiodol therapy for hepatocellular carcinoma. A single-center study based on a long-term follow-up.
    Ahmadzadehfar H; Habibi E; Ezziddin S; Wilhelm K; Fimmers R; Spengler U; Palmedo H; Strunk H; Schild HH; Biersack HJ; Risse J
    Nuklearmedizin; 2014; 53(2):46-53. PubMed ID: 24468919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.